Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin‐treated healthy men

References

• MRC/BHF Heart Protection Study of cholesterol‐lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 1999; 20: 725–41
   PubMed Web of Science ®Google Scholar
• Sever P. S., Dahlof B., Poulter N. R., Wedel H., Beevers G., Caulfield M., Collins R., Kjeldsen S. E., Kristinsson A., McInnes G. T., Mehlsen J., Nieminen M., O'Brien E., Ostergren J. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower‐than‐average cholesterol concentrations, in the Anglo‐Scandinavian Cardiac Outcomes Trial – Lipid Lowering Arm (ASCOT‐LLA): a multicentre randomised controlled trial. Lancet 2003; 361: 1149–58
   PubMed Web of Science ®Google Scholar
• Kido M., Ando K., Oba S., Fujita T. Renoprotective effect of pravastatin in salt‐loaded Dahl salt‐sensitive rats. Hypertens Res 2005; 28: 1009–15
   PubMed Web of Science ®Google Scholar
• Wilson S. H., Chade A. R., Feldstein A., Sawamura T., Napoli C., Lerman A., Lerman L. O. Lipid‐lowering‐independent effects of simvastatin on the kidney in experimental hypercholesterolaemia. Nephrol Dial Transpl 2003; 18: 703–9
   PubMed Web of Science ®Google Scholar
• Bayorh M. A., Layas M. F., Mann G., Feuerstein G. Z., Eatman D. The effect of diet on simvastatin and losartan enhancement of endothelial function. Clin Exp Hypertens 2007; 29: 311–25
   PubMed Web of Science ®Google Scholar
• Sandhu S., Wiebe N., Fried L. F., Tonelli M. Statins for improving renal outcomes: a meta‐analysis. J Am Soc Nephrol 2006; 17: 2006–16
   PubMed Web of Science ®Google Scholar
• Tonelli M., Moye L., Sacks F. M., Cole T., Curhan G. C. Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol 2003; 14: 1605–13
   PubMed Web of Science ®Google Scholar
• van Dijk M. A., Kamper A. M., van V. S., Souverijn J. H., Blauw G. J. Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease. Nephrol Dial Transpl 2001; 16: 2152–7
   PubMed Web of Science ®Google Scholar
• Paulsen L., Holm C., Bech J. N., Starklint J., Pedersen E. B. Effects of statins on renal sodium and water handling: acute and short‐term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans. Nephrol Dial Transpl 2008; 23: 1556–61
   PubMedGoogle Scholar
• Pedersen E. B., Eiskjaer H., Madsen B., Danielsen H., Egeblad M., Nielsen C. B. Effect of captopril on renal extraction of renin, angiotensin II, atrial natriuretic peptide and vasopressin, and renal vein renin ratio in patients with arterial hypertension and unilateral renal artery disease. Nephrol Dial Transpl 1993; 8: 1064–70
   PubMed Web of Science ®Google Scholar
• Jensen K. T., Carstens J., Ivarsen P., Pedersen E. B. A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 1997; 57: 529–40
   PubMed Web of Science ®Google Scholar
• Pedersen R. S., Bentzen H., Bech J. N., Pedersen E. B. Effect of water deprivation and hypertonic saline infusion on urinary AQP2 excretion in healthy humans. Am J Physiol Renal Physiol 2001; 280: F860–7
   PubMed Web of Science ®Google Scholar
• Jiang J., Roman R. J. Lovastatin prevents development of hypertension in spontaneously hypertensive rats. Hypertension 1997; 30: 968–74
   PubMed Web of Science ®Google Scholar
• Inman S. R., Caprio T. W., Drummond E., Mueller M., Entenman K. Enhanced acetylcholine‐induced dilation in afferent arterioles in simvastatin‐fed rats. Vascul Pharmacol 2006; 44: 17–21
   PubMed Web of Science ®Google Scholar
• Nesic Z., Todorovic Z., Stojanovic R., Basta‐Jovanovic G., Radojevic‐Skodric S., Velickovic R., Chatterjee P. K., Thiemermann C., Prostran M. Single‐dose intravenous simvastatin treatment attenuates renal injury in an experimental model of ischemia‐reperfusion in the rat. J Pharmacol Sci 2006; 102: 413–17
   PubMed Web of Science ®Google Scholar
• Athyros V. G., Mikhailidis D. P., Liberopoulos E. N., Kakafika A. I., Karagiannis A., Papageorgiou A. A., Tziomalos K., Ganotakis E. S., Elisaf M. Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. Nephrol Dial Transpl 2007; 22: 118–27
   PubMed Web of Science ®Google Scholar
• Atthobari J., Brantsma A. H., Gansevoort R. T., Visser S. T., Asselbergs F. W., van Gilst W. H., de Jong P. E., de Jong‐van den Berg L. T. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Nephrol Dial Transpl 2006; 21: 3106–14
   PubMed Web of Science ®Google Scholar
• Strippoli G. F., Navaneethan S. D., Johnson D. W., Perkovic V., Pellegrini F., Nicolucci A., Craig J. C. Effects of statins in patients with chronic kidney disease: meta‐analysis and meta‐regression of randomised controlled trials. Br Med J 2008; 336: 645–51
   PubMed Web of Science ®Google Scholar
• Ishikawa S., Kawasumi M., Saito T. Simvastatin inhibits the cellular signaling and proliferative action of arginine vasopressin in cultured rat glomerular mesangial cells. Endocrinology 1995; 136: 1954–61
   PubMed Web of Science ®Google Scholar
• Ide H., Fujiya S., Aanuma Y., Agishi Y. Effects of simvastatin, an HMG‐CoA reductase inhibitor, on plasma lipids and steroid hormones. Clin Ther 1990; 12: 410–20
   PubMed Web of Science ®Google Scholar
• Strey C. H., Young J. M., Lainchbury J. H., Frampton C. M., Nicholls M. G., Richards A. M., Scott R. S. Short‐term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non‐ischaemic heart failure. Heart 2006; 92: 1603–9
   PubMed Web of Science ®Google Scholar
• Emberson J. R., Ng L. L., Armitage J., Bowman L., Parish S., Collins R. N‐terminal Pro‐B‐type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study. J Am Coll Cardiol 2007; 49: 311–19
   PubMed Web of Science ®Google Scholar
• van der Linde N. A., Sijbrands E. J., Boomsma F., van den Meiracker A. H. Effect of low‐density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin. Hypertension 2006; 47: 1125–30
   PubMed Web of Science ®Google Scholar
• de S. S., Nielsen J., Olesen E. T., Dimke H., Kwon T. H., Frokiaer J., Nielsen S. Long‐term aldosterone treatment induces decreased apical but increased basolateral expression of AQP2 in CCD of rat kidney. Am J Physiol Renal Physiol 2007; 293: F87–99
   PubMed Web of Science ®Google Scholar
• Milionis H. J., Liberopoulos E. N., Achimastos A., Elisaf M. S., Mikhailidis D. P. Statins: another class of antihypertensive agents?. J Hum Hypertens 2006; 20: 320–35
   PubMed Web of Science ®Google Scholar
• He F. J., MacGregor G. A. How far should salt intake be reduced?. Hypertension 2003; 42: 1093–9
   PubMed Web of Science ®Google Scholar
• Sacks F. M., Svetkey L. P., Vollmer W. M., Appel L. J., Bray G. A., Harsha D., Obarzanek E., Conlin P. R., Miller E. R III., Simons‐Morton D. G., Karanja N., Lin P. H. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH‐Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3–10
   PubMed Web of Science ®Google Scholar